Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linifanib in Advanced Hepatocellular Carcinoma
NCT00517920Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2007
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of linifanib in hepatocellular carcinoma (HCC), sponsored by AbbVie Inc.. Started Sep 2007; status: completed.
02
Drugs
linifanib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT00517920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00517920.